trimebutine has been researched along with Colitis, Mucous in 12 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the efficacy and adverse drug reaction of trimebutine maleate in treating patients with functional dyspepsia (FD) coexisting with diarrhea dominant irritable bowel syndrome (IBS-D)." | 9.12 | [A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome]. ( Guo, JN; Li, HJ; Lin, YH; Yan, R; Zeng, ZY; Zhong, YQ; Zhu, J, 2007) |
| "Trimebutine improved symptoms and psychological adjustment to illness in irritable bowel syndrome in comparison with placebo." | 9.12 | The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome. ( Dumitraşcu, DL; Stănculete, M, 2006) |
| "Trimebutine maleate, which modulates the calcium and potassium channels, relieves abdominal pain in patients with irritable bowel syndrome." | 7.76 | Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome. ( Hou, X; Liu, Y; Long, Y; Qian, W; Tong, J, 2010) |
| "Fenoverine acts as a synchronizer of smooth muscle in modulating the intracellular influx of calcium." | 6.78 | [Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study]. ( Baek, IH; Choi, SC; Choung, RS; Jeen, YT; Kang, SH; Kim, KO; Kim, SY; Kim, YS; Koo, JS; Koo, YS; Lee, JH; Lee, SJ; Moon, JS; Park, JJ; Park, SC, 2013) |
| "To compare the differences in the therapeutic effect on irritable bowel syndrome (IBS) between acupuncture at Tianshu (ST 25) and Dachangshu (BL 25) and western medication with Trimebutine Maleate." | 5.15 | [Comparative study on irritable bowel syndrome treated with acupuncture and western medicine]. ( Lei, MN; Shi, ZM; Wang, QX; Zhu, YS, 2011) |
| "To observe the efficacy and adverse drug reaction of trimebutine maleate in treating patients with functional dyspepsia (FD) coexisting with diarrhea dominant irritable bowel syndrome (IBS-D)." | 5.12 | [A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome]. ( Guo, JN; Li, HJ; Lin, YH; Yan, R; Zeng, ZY; Zhong, YQ; Zhu, J, 2007) |
| "Trimebutine improved symptoms and psychological adjustment to illness in irritable bowel syndrome in comparison with placebo." | 5.12 | The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome. ( Dumitraşcu, DL; Stănculete, M, 2006) |
| "Trimebutine maleate has been used extensively, since the late 1960's, for the treatment of functional gastrointestinal disorders, including irritable bowel syndrome (IBS)." | 5.01 | Trimebutine: a state-of-the-art review. ( Salvioli, B, 2019) |
| "Trimebutine maleate, which modulates the calcium and potassium channels, relieves abdominal pain in patients with irritable bowel syndrome." | 3.76 | Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome. ( Hou, X; Liu, Y; Long, Y; Qian, W; Tong, J, 2010) |
| "We examined the effect of ramosetron, a potent serotonin (5-HT)(3)-receptor antagonist for irritable bowel syndrome with diarrhea, on conditioned fear stress (CFS)-induced defecation and normal (non-stressed) defecation in rats and compared ramosetron with the antidiarrheal agent loperamide and the spasmolytic agents trimebutine and tiquizium." | 3.74 | Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents. ( Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Sasamata, M, 2008) |
| "Fenoverine acts as a synchronizer of smooth muscle in modulating the intracellular influx of calcium." | 2.78 | [Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study]. ( Baek, IH; Choi, SC; Choung, RS; Jeen, YT; Kang, SH; Kim, KO; Kim, SY; Kim, YS; Koo, JS; Koo, YS; Lee, JH; Lee, SJ; Moon, JS; Park, JJ; Park, SC, 2013) |
| "Trimebutine was prescribed in accordance with the instructions for medical use: orally, 300 mg twice per day for 28 days." | 1.62 | [Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study]. ( Andreev, DN; Maev, IV, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andreev, DN | 1 |
| Maev, IV | 1 |
| Makarova, AA | 2 |
| Diukova, GM | 2 |
| Ruchkina, IN | 2 |
| Romashkina, NV | 2 |
| Indejkina, LK | 2 |
| Degterev, DA | 2 |
| Dbar, SR | 2 |
| Parfenov, AI | 2 |
| Salvioli, B | 1 |
| Kang, SH | 1 |
| Jeen, YT | 1 |
| Koo, JS | 1 |
| Koo, YS | 1 |
| Kim, KO | 1 |
| Kim, YS | 1 |
| Kim, SY | 1 |
| Moon, JS | 1 |
| Park, JJ | 1 |
| Baek, IH | 1 |
| Park, SC | 1 |
| Lee, SJ | 1 |
| Lee, JH | 1 |
| Choung, RS | 1 |
| Choi, SC | 1 |
| Rahman, MZ | 1 |
| Ahmed, DS | 1 |
| Mahmuduzzaman, M | 1 |
| Rahman, MA | 1 |
| Chowdhury, MS | 1 |
| Barua, R | 1 |
| Ishaque, SM | 1 |
| Long, Y | 1 |
| Liu, Y | 1 |
| Tong, J | 1 |
| Qian, W | 1 |
| Hou, X | 1 |
| Shi, ZM | 1 |
| Zhu, YS | 1 |
| Wang, QX | 1 |
| Lei, MN | 1 |
| Kountouras, J | 1 |
| Zavos, C | 1 |
| Chatzopoulos, D | 1 |
| Mearin, F | 1 |
| Zhong, YQ | 1 |
| Zhu, J | 1 |
| Guo, JN | 1 |
| Yan, R | 1 |
| Li, HJ | 1 |
| Lin, YH | 1 |
| Zeng, ZY | 1 |
| Hirata, T | 1 |
| Funatsu, T | 1 |
| Keto, Y | 1 |
| Akuzawa, S | 1 |
| Sasamata, M | 1 |
| Miyata, K | 1 |
| Dumitraşcu, DL | 1 |
| Stănculete, M | 1 |
2 reviews available for trimebutine and Colitis, Mucous
| Article | Year |
|---|---|
Trimebutine: a state-of-the-art review.
Topics: Animals; Digestive System Physiological Phenomena; Gastrointestinal Agents; Gastrointestinal Disease | 2019 |
[Drug treatment of irritable bowel syndrome: an unmet need].
Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled | 2007 |
6 trials available for trimebutine and Colitis, Mucous
| Article | Year |
|---|---|
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Ser | 2022 |
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Ser | 2022 |
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Ser | 2022 |
[Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].
Topics: Adult; Diarrhea; Duloxetine Hydrochloride; Female; Humans; Irritable Bowel Syndrome; Male; Pain; Ser | 2022 |
[Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study].
Topics: Abdominal Pain; Adult; Constipation; Diarrhea; Double-Blind Method; Drug Administration Schedule; Fe | 2013 |
Comparative efficacy and safety of trimebutine versus mebeverine in the treatment of irritable bowel syndrome.
Topics: Adolescent; Adult; Bangladesh; Female; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Pain Mea | 2014 |
[Comparative study on irritable bowel syndrome treated with acupuncture and western medicine].
Topics: Acupuncture Therapy; Adolescent; Adult; Aged; Child; Female; Humans; Irritable Bowel Syndrome; Male; | 2011 |
[A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome].
Topics: Adolescent; Adult; Case-Control Studies; Constipation; Diarrhea; Dyspepsia; Female; Gastrointestinal | 2007 |
The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
Topics: Adaptation, Psychological; Adult; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; | 2006 |
4 other studies available for trimebutine and Colitis, Mucous
| Article | Year |
|---|---|
[Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study].
Topics: Abdominal Pain; Dyspepsia; Female; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Male | 2021 |
Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
Topics: Acetylcholine; Animals; Body Weight; Colon; Disease Models, Animal; Dose-Response Relationship, Drug | 2010 |
H pylori infection and reflux oesophagitis.
Topics: Cohort Studies; Drug Therapy, Combination; Esophagitis; Gastroesophageal Reflux; Gastrointestinal Ag | 2004 |
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
Topics: Animals; Antidiarrheals; Benzimidazoles; Conditioning, Classical; Defecation; Fear; Irritable Bowel | 2008 |